Prevalence and Outcome of Hypermetabolism in Initial Prevalence and Outcome of Hypermetabolism in Initial Phase of Intensive Care Unit Patient: a Prospective Observational Study
NCT ID: NCT02002676
Last Updated: 2014-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
62 participants
OBSERVATIONAL
2013-12-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sepsis Metabolomics
NCT01649440
Fluid Balance and Body Weight Changes in Critically Ill Adult Patients
NCT04434079
Analysis of Risk Factors and Prognostic Predictive Value in Sepsis Patients With Nutritional Risk
NCT07278167
The Early Prediction of Sepsis in ICU
NCT05088850
Metabolic Trajectories and Protein Intake in Long-Stay Ventilated Intensive Care Unit (ICU) Patients
NCT07268274
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* APACHEⅡ score≥8
Exclusion Criteria
* Thyroid disease
* Tracheoesophageal fistula
* FiO2\>60 or PEEP\>12cm H2O in mechanical ventilate
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jinling Hospital, China
OTHER
Nanjing University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chao Wu
Ph.D.candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xinying Wang, MD
Role: STUDY_DIRECTOR
Nanjing University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanjing University School of Medicine
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013KLY-022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.